<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03517735</url>
  </required_header>
  <id_info>
    <org_study_id>2017/03</org_study_id>
    <nct_id>NCT03517735</nct_id>
  </id_info>
  <brief_title>Automated Postoperative Sedation After Cardiac Surgery</brief_title>
  <acronym>SEPOCA</acronym>
  <official_title>Postoperative Sedation After Cardiac Surgery : Comparison Between Manual Administration and Automated Sedation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMC Ambroise Paré</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares automated administration of propofol and remifentanil guided by the
      Bispectral index (BIS) versus manual administration for sedation after cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Automated sedation has the potential to improve patient care after cardiac surgery by
      adjusting drug doses to the minimum required for efficacy. Indeed, automated and continuous
      titration may avoid overdosing, improve hemodynamic stability and also decrease the mean time
      to tracheal extubation.

      Medsteer SAS developed a controller, EasyTiva device, allowing the closed-loop
      coadministration of propofol and remifentanil, guided by a Bispectral Index (BIS) monitor.

      Automated sedation is so facilitated by the BIS which permits continuous monitoring of
      electrocortical activity.

      This randomized monocentric trial compares the automated administration with manual
      intravenous administration of propofol-remifentanil for maintaining adequate depth of
      hypnosis (BIS 55-75) during sedation after cardiac surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adequate sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Percentage of time with BIS between 55 and 75 (BIS(55-75))</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Period of too deep sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Percentage of time with BIS values less than 55</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Period of too light sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Percentage of time with BIS values greater than 75</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Burst Suppression (bsr) during sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Presence of Burst Suppression defined by a rate &gt; 10% for at least one minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Richmond Agitation-Sedation Scale : from -5 (unarousable) to +4 (combative); the best value being 0 (alert &amp; calm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of pain during sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Behavioral Pain Scale : from 3 (no pain) to 12 (maximum pain) 3 subscales summed :
Numeric Scale for Facial expression : from 1 (relaxed) to 4 (grimacing)
Numeric Scale for Upper limb movements : from 1 (no movement) to 4 (permanently retracted)
Numeric Scale for Compliance with mechanical ventilation : from 1 (tolerating movement) to 4 (unable to control ventilation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical interventions</measure>
    <time_frame>6 hours</time_frame>
    <description>Number and causes of transient or permanent interruptions in automated administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic status during the sedation period</measure>
    <time_frame>6 hours</time_frame>
    <description>Evolution of hemodynamic parameters (composite : arterial blood pressure in mmHg and heart rate in bpm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation time</measure>
    <time_frame>6 hours</time_frame>
    <description>Duration of sedation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delay before awakening</measure>
    <time_frame>6 hours</time_frame>
    <description>Delay between the cessation of infusion of propofol and remifentanil and extubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose of hypnotic drug</measure>
    <time_frame>6 hours</time_frame>
    <description>Total amount of propofol during sedation period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose of analgesic drug</measure>
    <time_frame>6 hours</time_frame>
    <description>Total amount of remifentanil during sedation period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of consciousness after extubation</measure>
    <time_frame>9 hours</time_frame>
    <description>Richmond Agitation-Sedation Scale : from -5 (unarousable) to +4 (combative); the best value being 0 (alert &amp; calm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of pain after extubation</measure>
    <time_frame>9 hours</time_frame>
    <description>Behavioral Pain Scale : from 3 (no pain) to 12 (maximum pain) 3 subscales summed :
Numeric Scale for Facial expression : from 1 (relaxed) to 4 (grimacing)
Numeric Scale for Upper limb movements : from 1 (no movement) to 4 (permanently retracted)
Numeric Scale for Compliance with mechanical ventilation : from 1 (tolerating movement) to 4 (unable to control ventilation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awareness during the sedation period</measure>
    <time_frame>48 hours</time_frame>
    <description>Awareness standardized questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Anesthesia</condition>
  <condition>Sedation</condition>
  <condition>Surgery, Cardiac</condition>
  <arm_group>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Automated administration of Propofol and Remifentanil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual postoperative sedation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Manual administration of Propofol and Remifentanil.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EasyTiva (algorithm is the property of Medsteer SAS)</intervention_name>
    <description>Propofol and Remifentanil are administered automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 55 and 75.</description>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>The dosage is modified automatically by the device or according to the new medical prescription.</description>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
    <arm_group_label>Manual postoperative sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>The dosage is modified automatically by the device or according to the new medical prescription.</description>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
    <arm_group_label>Manual postoperative sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac surgical procedure requiring postoperative sedation

          -  Low operative risk : EuroSCORE 2 ≤ 5%

          -  Consent for participation

          -  Affiliation to the social security system

        Exclusion Criteria:

          -  Pregnant or breastfeeding women

          -  Neurological or muscular disorder

          -  Pacemaker

          -  Hypersensitivity to propofol or remifentanil

          -  Communication difficulties or neuropsychiatric disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry Chazot, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital FOCH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Squara, MD</last_name>
    <phone>(+33)1 46 41 89 71</phone>
    <email>pierre.squara@orange.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CMC Ambroise Paré</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <state>Ile-de-France</state>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Squara, MD</last_name>
      <phone>(+33)1 46 41 89 71</phone>
      <email>pierre.squara@orange.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Squara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Estagnasie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain Brusset, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Claude Dib, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier Belliard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.</citation>
    <PMID>21233500</PMID>
  </results_reference>
  <results_reference>
    <citation>Le Guen M, Liu N, Bourgeois E, Chazot T, Sessler DI, Rouby JJ, Fischler M. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial. Intensive Care Med. 2013 Mar;39(3):454-62. doi: 10.1007/s00134-012-2762-2. Epub 2012 Dec 6.</citation>
    <PMID>23223772</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2018</study_first_submitted>
  <study_first_submitted_qc>May 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2018</study_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

